iBio, Inc. Balance Sheet
IBIO|13 years of annual SEC 10-K data (FY2013-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 13 fiscal years. All figures from audited SEC 10-K filings.
iBio, Inc. had $23M in total assets and $15M in shareholders' equity as of FY2025.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score -1.36 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $8.6M | $4.3M | $4.3M | $22.7M | $55.1M | $4.4M | $8.1M | $23.0M | $23.0M | $9.5M | $3.6M | $4.4M | $2.8M |
| Accounts Receivable | - | $1.0M | $1.0M | $426.0K | $426.0K | $75.0K | $97.0K | $75.0K | $175.0K | $484.0K | $445.0K | $205.0K | $351.0K |
| Inventory | - | $0 | - | $3.9M | - | - | - | - | - | - | - | - | - |
| Current Assets | $9.7M | $26.3M | $26.3M | $45.1M | $104.6M | $61.7M | $4.8M | $16.3M | $8.6M | $23.9M | $10.1M | $3.9M | $6.9M |
| PP&E (Net) | $3.2M | $4.2M | $4.2M | $36.7M | $8.6M | $3.7M | $24.4M | $25.2M | $25.6M | $25.6M | $13.0K | $6.0K | $3.0K |
| Total Assets | $23.2M | $41.2M | $41.2M | $99.4M | $147.0M | $42.2M | $30.6M | $43.1M | $36.0M | $51.6M | $12.5M | $6.5M | $9.8M |
| Current Liabilities | $6.1M | $22.1M | $21.6M | $30.4M | $6.6M | $5.2M | $3.5M | $2.0M | $2.0M | $2.3M | - | $395.0K | $3.6M |
| Shareholders' Equity | $14.9M | $15.4M | $15.4M | $63.5M | $108.6M | $56.6M | $2.5M | $16.2M | $8.9M | $9.9M | $11.2M | $5.1M | $196.0K |